Stockreport

Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA

ORION CORP NEW UNSP/ADR  (ORINY) 
PDF ORION CORPORATION PRESS RELEASE 20 APRIL 2026 at 16.00 EEST         Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA Orion Corpo [Read more]